Skip to content

Multi center prospective study on the reversal effect of interferon combined with Qiu's Er Teng Tang on HPV infection in damp heat syndrome Real world research

Multi center prospective study on the reversal effect of interferon combined with Qiu's Er Teng Tang on HPV infection in damp heat syndrome Real world research

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2024000394
Enrollment
Unknown
Registered
2024-09-06
Start date
2024-09-15
Completion date
Unknown
Last updated
2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HPV infection

Interventions

Control:None
Interferon group:External use of interferon alpha-2b suppository
Interferon+Traditional Chinese Medicine Group:Interferon combined with Qiu's Er Teng decoction

Sponsors

Zhejiang University of Traditional Chinese Medicine First Affiliated Hospital: Zhejiang Hospital of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Select patients who have been diagnosed with HPV infection through clinical auxiliary examination and confirmed pathological = CIN I through vaginal colposcopy aged 18-65 years old and have sexual intercourse and have been treated in multiple centers; Traditional Chinese Medicine (TCM) syndrome differentiation is based on damp heat and downward pressure.

Exclusion criteria

Exclusion criteria: (1) Individuals under 18 years old or over 65 years old; (2) Pregnant or lactating women; (3) History of allergies smoking oral contraceptives and HPV vaccination; (4) Severe heart lung liver and kidney dysfunction; (5) Individuals with weakened immune function immune system diseases or malignant tumors who have been treated with immunosuppressants; (6) Patients with acute reproductive tract inflammation; (7) Menstrual disorders; (8) Have used antiviral drugs (oral or vaginal) within 3 months.

Design outcomes

Primary

MeasureTime frame
HPV clearance rate;

Countries

China

Contacts

Public ContactXinyan Wang

Zhejiang University of Traditional Chinese Medicine First Affiliated Hospital: Zhejiang Hospital of Traditional Chinese Medicine

13989843487@139.com13989843487

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026